ATE424832T1 - Präbiotische kombinationsprodukte - Google Patents

Präbiotische kombinationsprodukte

Info

Publication number
ATE424832T1
ATE424832T1 AT04808876T AT04808876T ATE424832T1 AT E424832 T1 ATE424832 T1 AT E424832T1 AT 04808876 T AT04808876 T AT 04808876T AT 04808876 T AT04808876 T AT 04808876T AT E424832 T1 ATE424832 T1 AT E424832T1
Authority
AT
Austria
Prior art keywords
prebiotic
prophylaxis
small amount
combination products
prebiotic combination
Prior art date
Application number
AT04808876T
Other languages
English (en)
Inventor
Jan Piene
Original Assignee
Nova Biotics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Biotics As filed Critical Nova Biotics As
Application granted granted Critical
Publication of ATE424832T1 publication Critical patent/ATE424832T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
AT04808876T 2003-12-12 2004-12-10 Präbiotische kombinationsprodukte ATE424832T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter

Publications (1)

Publication Number Publication Date
ATE424832T1 true ATE424832T1 (de) 2009-03-15

Family

ID=30439651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04808876T ATE424832T1 (de) 2003-12-12 2004-12-10 Präbiotische kombinationsprodukte

Country Status (5)

Country Link
EP (1) EP1696937B1 (de)
AT (1) ATE424832T1 (de)
DE (1) DE602004019968D1 (de)
NO (1) NO320546B1 (de)
WO (1) WO2005056023A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530447B2 (en) * 2005-10-24 2013-09-10 Nestec S.A. Dietary fiber formulation and method of administration
AU2007317780B2 (en) 2006-11-07 2013-06-13 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
DE102008059070B4 (de) * 2008-11-26 2019-05-16 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
EP2216036A1 (de) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus-rhamnosus-NCC4007, probiotische Mischung und Gewichtskontrolle
GB0907019D0 (en) * 2009-04-24 2009-06-03 Oxford Nutrascience Ltd Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
DE102011012494A1 (de) 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
US11253531B2 (en) 2011-08-11 2022-02-22 Nutritional Therapeutics, Inc. Lipid supplements for reducing nerve action potentials
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
EP3139904B1 (de) 2014-05-05 2021-03-03 Basf Se Formulierung von fettlöslichem vitamin
US20170042950A1 (en) * 2015-08-11 2017-02-16 Shaklee Corporation Materials and methods for improving gastrointestinal health
US20190275076A1 (en) * 2018-03-08 2019-09-12 Coöperatie Koninklijke Cosun U.A. Dietary fiber compositions for curative or prophylactic treatment of obesity and other conditions
EP3556226B1 (de) * 2018-04-20 2021-01-20 Raab Vitalfood GmbH Komplex-synbiotikum zum aufbau einer gesunden darmflora
EP3806879A4 (de) * 2018-06-15 2022-03-09 University Of Tasmania Präparat zur behandlung entzündlicher darmerkrankungen mit einem ganzen pflanzenfaserextrakt aus zuckerrohr
CN110652009B (zh) * 2019-10-23 2023-03-17 四川拜奥德克生物科技有限公司 一种高纤维膳食补充剂用于预防及改善骨代谢相关疾病的新用途
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123903T5 (es) * 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
JP3618355B2 (ja) * 1995-12-26 2005-02-09 オネスタ・ニュートリション・インコーポレーテッド 食物繊維デリバリーシステム
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6436446B1 (en) * 1999-07-30 2002-08-20 Pharmavite Llc Composition for increasing bone density
CA2400969C (en) * 2000-03-01 2011-04-19 Societe Des Produits Nestle S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine
EP1175905A1 (de) * 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Ernährungszusammensetzung
EP1243273A1 (de) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Zubereitung enthaltend einen praebiotischen Stoff für die Behandlung von Entzündungen und abnormale Aktivierung von nicht-spezifischen immunologischen Parametern
EP1386546A1 (de) * 2002-07-31 2004-02-04 Ca.Di.Group S.r.l. Kombination aus präbiotischen und verdauungsfördernden Lebensmitteln zur Verbesserung und Hilfe der körperlichen Gesundheit und der Leistungsfähigkeit des Darms

Also Published As

Publication number Publication date
EP1696937B1 (de) 2009-03-11
NO320546B1 (no) 2005-12-19
WO2005056023A1 (en) 2005-06-23
DE602004019968D1 (de) 2009-04-23
NO20035566L (no) 2005-06-13
NO20035566D0 (no) 2003-12-12
EP1696937A1 (de) 2006-09-06

Similar Documents

Publication Publication Date Title
ATE424832T1 (de) Präbiotische kombinationsprodukte
TW200505449A (en) Pharmaceutical compositions and dosage forms of thalidomide
Yoshida et al. Correlation between dental and nutritional status in community‐dwelling elderly Japanese
CY1116093T1 (el) Χρηση νιντεντανιμπης για την αγωγη της πνευμονικης ινωσεως
EA200600041A1 (ru) Применение изомальта (смеси 1,6-gps и 1,1-gpm) в качестве пребиотика, в частности, для получения лекарственного средства для лечения кишечных заболеваний
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
CY1121465T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια της φλεγμονωδους νοσου του εντερου
TW200621317A (en) Pharmaceutical composition
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
IL180979A (en) Isoindulin compounds and their use
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
EA200900044A1 (ru) Замещенные производные 1,3-дифенилпропана, получение и их применение
CO6400186A2 (es) Tabletas de acetato de ulipristal
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
BRPI0615989B8 (pt) formulação farmacêutica de dosagem oral
TW200738269A (en) Oral delivery of therapeutic agents using tight junction agonists
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
RU2009115791A (ru) Смесь солей железа и меди, маскирующая металлический вкус
AR013739A1 (es) Composiciones de agentes reductores de lipidos
RS20060662A (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
Busquets et al. Omega‐3 and omega‐3/curcumin‐enriched fruit juices decrease tumour growth and reduce muscle wasting in tumour‐bearing mice
MX2009010763A (es) NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
TR200704897A1 (tr) Uzatılmış salım sağlayan gliklazid formülasyonları@
HRP20161166T1 (hr) Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties